Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 2Phase 2/3 1Phase 1 1

Status

Completed 21Recruiting 9Terminated 7Unknown 4Active not recruiting 4Withdrawn 3Suspended 1

Sponsor Class

OTHER 5INDUSTRY 2OTHER_GOV 1NETWORK 1

Study Type

Interventional 8Observational 1

Sponsor

Cancer Type

CNS 9

Conditions

Glioblastoma 9Recurrence 1Oligodendroglioma 1Neoplasms 1Neoplasm Recurrence, Local 1Medulloblastoma 1Lymphoma, Large B-Cell, Diffuse 1Glioma 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 45Radiotherapy 17Magnetic Resonance Spectroscopy 17Specimen Handling 14pembrolizumab 12Bevacizumab 12Lomustine 9Radiation 8fludarabine 7Cyclophosphamide 7atezolizumab 4Biopsy 4olaparib 3Transurethral Resection of Bladder 3Surgical Procedures, Operative 3Nivolumab 3Leukapheresis 3D2C7-(scdsFv)-PE38KDEL 3Blood Specimen Collection 3Aminolevulinic Acid 3regorafenib 2fluciclovine F-18 2contrast agent BR1 2antisecretory factor 2abemaciclib 2Restraint, Physical 2Re-Irradiation 2Radiation Dose Hypofractionation 2Palliative Care 2Oncolytic Virotherapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

9 trials
RecentStart dateEnrollment
Recruiting × Glioblastoma × Lomustine × Clear all
NCT03970447 2026-05-15

GBM AGILE

Global Coalition for Adaptive Research

Phase 2/3 Recruiting
2,250 enrolled
CNS

Glioblastoma, Recurrence

NCT05902169 2026-04-24

SONOBIRD

CarThera

Phase 3 Recruiting
560 enrolled
CNS

Glioblastoma

NCT07100730 2026-04-16

IPAX BrIGHT

Telix Pharmaceuticals (Innovations) Pty Limited

Phase 3 Recruiting
50 enrolled
CNS

Brain Neoplasms, Glioblastoma, Neoplasm Recurrence, Local, Neoplasms, Central Nervous System Neoplasms

NCT06419946 2026-04-13

Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

Vastra Gotaland Region

Phase 3 Recruiting
200 enrolled
CNS

Glioblastoma

NCT05904119 2026-02-17

LEGATO

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting
411 enrolled
CNS

Glioblastoma

NCT07145112 2025-10-09

Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma

University of California, Davis

Phase 1 Recruiting
20 enrolled
CNS

Glioblastoma

NCT04863950 2025-08-27

Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma

The University of Texas Health Science Center at San Antonio

Phase 2 Recruiting
25 enrolled
CNS

Glioblastoma

NCT06177964 2025-08-17

Lerapolturev (PVSRIPO) in GBM

Duke University

Phase 2 Recruiting
92 enrolled
CNS

Glioblastoma, Glioma

NCT06283927 2024-02-28

RECSUR

Erasmus Medical Center

Recruiting
464 enrolled
CNS

Astrocytoma, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡